Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Lung Cancer |
Free Subscription
7 Ann Surg Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Pleural Invasion in Non-small Cell Lung Cancer: An Important Characteristic
during Clinical Decision-Making.
Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15401.
PubMed
ASO Author Reflections: How Does Emphysema Contribute to Poor Prognosis After
Lung Cancer Surgery?
Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15171.
PubMed
Surgery in Stage IV Non-small Cell Lung Cancer: Good Time for a Chance.
Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15308.
PubMed
ASO Author Reflections: The Clinical Use of Dual-Region Radiomics-Based Machine
Learning in the Identification of Subcarinal Lymph Node Metastasis of Non-small
Cell Lung Cancer.
Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15271.
PubMed
ASO Author Reflections: Venous Thromboembolism in Peritoneal Mesothelioma.
Ann Surg Oncol. 2024;31:3785-3786.
PubMed
Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability.
Ann Surg Oncol. 2024;31:4031-4041.
PubMed
Abstract available
Malignant Chest Wall Tumors: Complex Defects and Their Management-A Review of 181
Cases.
Ann Surg Oncol. 2024;31:3675-3683.
PubMed
Abstract available
A Rare Pulmonary Metastasis of Uveal Melanoma Diagnosed Through Endobronchial
Endosonography and Fine Needle Aspiration: A Case Report.
Arch Bronconeumol. 2024;60:298-299.
PubMed
Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior
immunotherapy in patients with driver-gene negative advanced non-small cell lung
cancer.
BMC Cancer. 2024;24:569.
PubMed
Abstract available
Tenascin C as a novel zinc finger protein 750 target regulating the
immunogenicity via DNA damage in lung squamous cell carcinoma.
BMC Cancer. 2024;24:561.
PubMed
Abstract available
Immunotherapy for metastatic non-small cell lung cancer: Is it really a
no-brainer?
Cancer. 2024 May 6. doi: 10.1002/cncr.35350.
PubMed
Commemorating the 20th anniversary of the discovery of epidermal growth factor
receptor mutation in lung cancer: Translational research at its best.
Cancer. 2024 May 8. doi: 10.1002/cncr.35353.
PubMed
Top advances of the year: Perioperative therapy for lung cancer.
Cancer. 2024 May 8. doi: 10.1002/cncr.35357.
PubMed
Abstract available
LILRB2 Inhibition Enhances Radiation Sensitivity in Non-Small Cell Lung Cancer by
Attenuating Radiation-Induced Senescence.
Cancer Lett. 2024 May 3:216930. doi: 10.1016/j.canlet.2024.216930.
PubMed
Abstract available
Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions.
Chest. 2024;165:e133-e136.
PubMed
Abstract available
Treating Lung Metastases: More Evidence for Equipoise.
Chest. 2024;165:1037-1038.
PubMed
Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous
Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy.
Chest. 2024;165:1247-1259.
PubMed
Abstract available
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal
Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade,
Intrathecal Chemotherapy, or Radiation Therapy Alone.
Clin Lung Cancer. 2024 Apr 10:S1525-7304(24)00048.
PubMed
Abstract available
Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World
Outcomes After Two Years of Therapy (COPILOT).
Clin Lung Cancer. 2024 Apr 15:S1525-7304(24)00051.
PubMed
Abstract available
Risk of Venous Thromboembolism in Patients With Stage III and IV Non-Small-Cell
Lung Cancer: Nationwide Descriptive Cohort Study.
Clin Lung Cancer. 2024 Apr 11:S1525-7304(24)00047.
PubMed
Abstract available
Video-Assisted Thoracoscopic Surgery Versus Thoracotomy Following Neoadjuvant
Immunochemotherapy in Resectable Stage III Non-Small Cell Lung Cancer Among
Chinese Populations: A Multi-Center Retrospective Cohort Study.
Clin Lung Cancer. 2024 Apr 2:S1525-7304(24)00042.
PubMed
Abstract available
Machine Learning-Based Prediction of Pathological Responses and Prognosis After
Neoadjuvant Chemotherapy for Non-Small-Cell Lung Cancer: A Retrospective Study.
Clin Lung Cancer. 2024 Apr 12:S1525-7304(24)00049.
PubMed
Abstract available
Metastatic Lung Adenocarcinoma Received Combined 177 Lu-FAP-2286 Radiation
Therapy and Targeted Therapy.
Clin Nucl Med. 2024;49:569-571.
PubMed
Abstract available
Solitary Pulmonary Perivascular Epithelial Cell Tumor Mimicking Pulmonary
Metastasis on 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine
Tumor.
Clin Nucl Med. 2024 Apr 17. doi: 10.1097/RLU.0000000000005235.
PubMed
Abstract available
FDG PET/CT in a Case of Solitary Mixed Squamous Cell and Glandular Papilloma of
the Lung With High CEA Level.
Clin Nucl Med. 2024;49:e288-e289.
PubMed
Abstract available
68Ga-FAPI PET/CT in an Interesting Case of Metastatic Pulmonary Meningioma.
Clin Nucl Med. 2024 Mar 25. doi: 10.1097/RLU.0000000000005161.
PubMed
Abstract available
The use of diagnostic complex robotic-assisted segmentectomy in the management of
incidental and screen-detected pulmonary nodules.
Eur J Cardiothorac Surg. 2024;65:ezae139.
PubMed
Abstract available
Pulmonary gangliocytic paraganglioma: An under-recognized mimic of carcinoid
tumor.
Hum Pathol. 2024;146:23-27.
PubMed
Abstract available
Comprehensive molecular analyses of cuproptosis-related genes with regard to
prognosis, immune landscape, and response to immune checkpoint blockers in lung
adenocarcinoma.
J Cancer Res Clin Oncol. 2024;150:246.
PubMed
Abstract available
Promotion of an Antitumor Immune Program by a Tumor-specific,
Complement-activating Antibody.
J Immunol. 2024;212:1589-1601.
PubMed
Abstract available
Commentary: "HIIT"ing the Jackpot with Prehabilitation before Minimally Invasive
Lung Cancer Surgery.
J Thorac Cardiovasc Surg. 2024 May 3:S0022-5223(24)00374.
PubMed
Comprehensive Review of ROS1 Tyrosine Kinase Inhibitors-Classified by Structural
Designs and Mutation Spectrum (Solvent Front Mutation [G2032R] and Central
beta-Sheet 6 [Cbeta6] Mutation [L2086F]).
J Thorac Oncol. 2024;19:706-718.
PubMed
Abstract available
Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.
J Thorac Oncol. 2024;19:829-838.
PubMed
Abstract available
Should the TNM Staging of NSCLC Evolve Beyond Anatomical Descriptors?
J Thorac Oncol. 2024;19:663-665.
PubMed
Artificial Intelligence Enhances NSCLC Care by Predicting Treatment Outcomes,
Validating Neoadjuvant Therapies, and Improving Precision.
J Thorac Oncol. 2024;19:666-667.
PubMed
ERBB2 Amplification in NSCLC: How Many Faces?
J Thorac Oncol. 2024;19:668-670.
PubMed
Con: "Is Spread Through Air Spaces an In Vivo Phenomenon or an Inducible
Artifact?".
J Thorac Oncol. 2024;19:671-676.
PubMed
Pro: "Is Spread Through Air Spaces an In Vivo Phenomenon or an Inducible
Artifact?".
J Thorac Oncol. 2024;19:677-697.
PubMed
Abstract available
Lung Cancer in Brunei Darussalam.
J Thorac Oncol. 2024;19:698-705.
PubMed
Osimertinib Versus Durvalumab Versus Observation After Chemoradiation in
Unresectable EGFR-Mutant NSCLC.
J Thorac Oncol. 2024;19:e5-e6.
PubMed
Comment on "Consolidation Osimertinib Versus Durvalumab following Concurrent
Chemoradiation in Unresectable EGFR-Mutant NSCLC".
J Thorac Oncol. 2024;19:e6-e7.
PubMed
Response letter by Nassar et al.
J Thorac Oncol. 2024;19:e7-e8.
PubMed
Identification of a novel ALK inhibitor-sensitive PRKCE-ALK gene fusion in lung
adenocarcinoma.
Lung Cancer. 2024;191:107797.
PubMed
Proteomic profiling of tumor microenvironment and prognosis risk prediction in
stage I lung adenocarcinoma.
Lung Cancer. 2024;191:107791.
PubMed
Abstract available
Management of sotorasib-related adverse events and hepatotoxicities following
anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers
and practical guidance proposal.
Lung Cancer. 2024;191:107789.
PubMed
Abstract available
Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the
efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expression.
Lung Cancer. 2024;191:107788.
PubMed
Abstract available
Is the onset of immune-related adverse events themselves a prognostic factor or a
confounding factor?
Lung Cancer. 2024;191:107561.
PubMed
Establishing mesothelioma patient-derived organoid models from malignant pleural
effusions.
Lung Cancer. 2024;191:107542.
PubMed
Abstract available
A pragmatic guide for management of adverse events associated with lorlatinib.
Lung Cancer. 2024;191:107535.
PubMed
Abstract available
The promotion of non-small cell lung cancer progression by collagen and calcium
binding EGF domain 1 is mediated through the regulation of ERK/JNK/P38
phosphorylation by reactive oxygen species.
Mol Carcinog. 2024 May 10. doi: 10.1002/mc.23736.
PubMed
Abstract available
Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative
breast cancer.
PLoS Genet. 2024;20:e1011236.
PubMed
Abstract available
Retraction: miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by
targeting TGFBR1 and CCNE2.
PLoS Genet. 2024;20:e1011270.
PubMed
Sex differences in prognosis factors in patients with lung cancer: A nationwide
retrospective cohort study in Korea.
PLoS One. 2024;19:e0300389.
PubMed
Abstract available
Clinical usability of 3D gradient-echo-based ultrashort echo time imaging: Is it
enough to facilitate diagnostic decision in real-world practice?
PLoS One. 2024;19:e0296696.
PubMed
Abstract available
Does improved nurse staffing impact patient outcomes in cancer? Association
between chronic diseases and mortality among older adult patients with lung
cancer in Korea.
PLoS One. 2024;19:e0301010.
PubMed
Abstract available
Epigenome-wide association study of lung cancer among never smokers in two
prospective cohorts in Shanghai, China.
Thorax. 2024 May 3:thorax-2023-220352. doi: 10.1136/thorax-2023-220352.
PubMed
Abstract available
Epigenetic clock as the new hand of time for lung cancer in never smokers.
Thorax. 2024 May 3:thorax-2024-221393. doi: 10.1136/thorax-2024-221393.
PubMed
Thank you for your interest in scientific medicine.